Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells.
about
Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?The Fate of the Tumor in the Hands of Microenvironment: Role of TAMs and mTOR Pathway.Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation.Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy.Biodegradable poly (lactic acid-co-glycolic acid) scaffolds as carriers for genetically-modified fibroblasts.Chitosan nanoparticle-mediated co-delivery of shAtg-5 and gefitinib synergistically promoted the efficacy of chemotherapeutics through the modulation of autophagy.Multifunctional nanoparticles for cancer immunotherapy.Novel nanoparticulate systems for lung cancer therapy: an updated review.Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery.Programmable biomaterials for dynamic and responsive drug delivery.Emerging nanotechnologies for cancer immunotherapyDelivery strategies and potential targets for siRNA in major cancer typesGold Nanobeacons for Tracking Gene Silencing in Zebrafish.TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments.Tumor-Associated Macrophages as Target for Antitumor Therapy.Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Biomaterials for Abrogating Metastasis: Bridging the Gap between Basic and Translational Research.
P2860
Q30360668-4D55FA1B-CBAB-4C91-A77C-B5EF13A8A6ECQ33364555-90552119-C005-4C44-9CC2-E245BB7288E6Q33776949-C9849BD7-3D71-487A-A637-ADA7103F0F4AQ36043634-FA815C1C-03BA-4282-BFF2-1F9F537AFADBQ36336234-FB116C78-3279-479B-AFFE-1AED33549CCEQ37747755-69D9435E-A351-4380-886C-3FFCB7F26D4CQ38744042-D8D2E94C-3C5E-4A42-989E-313D461BC81DQ38762917-599FD4D9-9DBF-4DA6-8BDF-33510837DF9EQ38811957-EF16A496-B147-43E8-A3CE-520D4348506EQ38837032-3B7CEF76-3C03-4938-9014-9A3F9CE6D5BBQ38837036-BE9F393C-69DC-4ECD-B8D1-813E95E255F1Q38853191-36401FC4-4E4E-4B8D-8973-1D7A18D7EF76Q38880920-46F5360E-D0BF-4AF7-AFDE-DB146B2EFBBEQ39046367-63819DBC-A1FD-4564-A3A6-D3E9CCAE1FCFQ39403895-650C66F7-C08F-423C-A0D8-AFA5CB5AB97DQ47962563-3491C504-9780-49D7-A733-DD01F0E51D23Q48308048-AA44ABE8-9B5D-41FC-A17F-7E3EFC3E39DFQ51231785-50D3EF9F-58AA-47C5-8B85-9787D48E7ECC
P2860
Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dual targeted immunotherapy vi ...... macrophages and cancer cells.
@en
Dual targeted immunotherapy vi ...... macrophages and cancer cells.
@nl
type
label
Dual targeted immunotherapy vi ...... macrophages and cancer cells.
@en
Dual targeted immunotherapy vi ...... macrophages and cancer cells.
@nl
prefLabel
Dual targeted immunotherapy vi ...... macrophages and cancer cells.
@en
Dual targeted immunotherapy vi ...... macrophages and cancer cells.
@nl
P2093
P2860
P50
P921
P356
P1476
Dual targeted immunotherapy vi ...... d macrophages and cancer cells
@en
P2093
Chenchen Bao
Daxiang Cui
Elazer R Edelman
Furong Tian
Natalie Artzi
P2860
P304
P356
10.1002/ADFM.201501283
P407
P577
2015-06-01T00:00:00Z